Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alina Tscherne
Observed names:
A. Tscherne,
Tscherne, Alina
Institutions:
Medical University of Vienna,
Ludwig-Maximilians-Universität München
Observed institutions:
University of Parma,
Philipps University of Marburg,
German Center for Infection Research,
German Center for Lung Research,
Institut für Mikrobiologie der Bundeswehr,
Medical University of Vienna,
Ludwig-Maximilians-Universität München
show all 7
ORCID:
0000-0001-6066-8246
Observed ORCID:
0000-0001-6066-8246
OpenAlex ID:
A5043617981
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
2021
·
Alina Tscherne
, Jan Hendrik Schwarz
, et al.
·
Proceedings of the National Academy of Sciences
·
93
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
2021
·
Berislav Bošnjak
, Ivan Odak
, et al.
·
Frontiers in Immunology
·
51
PDF
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
2022
·
Christian Meyer zu Natrup
, Alina Tscherne
, et al.
·
Journal of Clinical Investigation
·
31
PDF
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging
2020
·
Oleg Timofeev
, Lukas Koch
, et al.
·
Cancer Research
·
30
PDF
A review of currently licensed mucosal COVID-19 vaccines
2025
·
Alina Tscherne
, Florian Krammer
·
Vaccine
·
23
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome
2022
·
Anahita Fathi
, Christine Dahlke
, et al.
·
Nature Communications
·
20
PDF
Evaluation of in vitro antimicrobial susceptibility of Bacillus anthracis strains isolated during anthrax outbreaks in Italy from 1984 to 2017
2019
·
Viviana Manzulli
, Antonio Fasanella
, et al.
·
Journal of Veterinary Science
·
20
PDF
Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology
2025
·
Alina Tscherne
, Pablo Guardado-Calvo
, et al.
·
Frontiers in Immunology
·
18
PDF
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trial
2024
·
Matthijs P Raadsen
, Christine Dahlke
, et al.
·
The Lancet Infectious Diseases
·
18
Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method
2022
·
Alina Tscherne
, Enrico Mantel
, et al.
·
Microorganisms
·
15
PDF
Mucosal COVID-19 vaccines in clinical development
2025
·
Alina Tscherne
, Weina Sun
, et al.
·
Vaccine
·
13
A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection
2023
·
Mareike Kubinski
, Jana Beicht
, et al.
·
Frontiers in Immunology
·
12
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice
2023
·
Georgia Kalodimou
, Sylvia Jany
, et al.
·
Viruses
·
8
PDF
Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans
2024
·
Alina Tscherne
, Georgia Kalodimou
, et al.
·
Vaccines
·
7
PDF
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19
2024
·
Sabrina Clever
, Lisa-Marie Schünemann
, et al.
·
Vaccines
·
7
PDF
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
2023
·
Martin C. Langenmayer
, Anna-Theresa Luelf-Averhoff
, et al.
·
Pathogens
·
7
PDF
Vaccines and therapeutics for Andes hantavirus
2026
·
Alina Tscherne
, Nico Joel Halwe
, et al.
·
npj Viruses
·
5
PDF
Design and evaluation of a poly-epitope based vaccine for the induction of influenza A virus cross-reactive CD8 + T cell responses
2025
·
Sharmistha Dam
, Alina Tscherne
, et al.
·
Scientific Reports
·
5
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
2024
·
Sabrina Clever
, Leonard Limpinsel
, et al.
·
Viruses
·
5
PDF
NOTIFy (non-toxic lyophilized field)-FISH for the identification of biological agents by Fluorescence in situ Hybridization
2020
·
Karin Aistleitner
, Tina Sieper
, et al.
·
PLoS ONE
·
5
PDF
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection
2025
·
Asisa Volz
, Sabrina Clever
, et al.
·
npj Vaccines
·
3
Generating MVA-Vector Vaccine Candidates and Testing Them in Animal Models
2024
·
Alina Tscherne
, Christian Meyer zu Natrup
, et al.
·
Methods in molecular biology
·
3
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study
2024
·
Satendra Kumar
, Liangliang Nan
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection
2024
·
Mareike Kubinski
, Jana Beicht
, et al.
·
Vaccines
·
3
PDF
Seven decades after the Asian influenza pandemic: A historical review about immunity and vaccines against H2N2
2026
·
Alina Tscherne
, Florian Krammer
·
Vaccine
·
2
Show more works
View as search
Works count:
34
Citation count:
409
H-index:
12
I10-index:
12
Year
Topic
Type